Compare Novartis with PAE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs PAE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS PAE NOVARTIS/
PAE
 
P/E (TTM) x -410.4 0.5 - View Chart
P/BV x 2.1 - - View Chart
Dividend Yield % 1.6 0.0 -  

Financials

 NOVARTIS   PAE
EQUITY SHARE DATA
    NOVARTIS
Mar-21
PAE
Mar-21
NOVARTIS/
PAE
5-Yr Chart
Click to enlarge
High Rs77010 7,389.6%   
Low Rs5012 26,648.9%   
Sales per share (Unadj.) Rs154.50 1,238,018.2%  
Earnings per share (Unadj.) Rs8.5-5.2 -161.8%  
Cash flow per share (Unadj.) Rs13.4-5.2 -259.0%  
Dividends per share (Unadj.) Rs10.000-  
Avg Dividend yield %1.60-  
Book value per share (Unadj.) Rs289.2-42.2 -685.5%  
Shares outstanding (eoy) m24.6910.42 236.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.1512.6 0.8%   
Avg P/E ratio x75.1-1.2 -6,387.6%  
P/CF ratio (eoy) x47.5-1.2 -3,990.0%  
Price / Book Value ratio x2.2-0.1 -1,507.6%  
Dividend payout %118.10-   
Avg Mkt Cap Rs m15,69164 24,486.6%   
No. of employees `000NANA-   
Total wages/salary Rs m1,0854 28,331.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,8140 2,933,461.5%  
Other income Rs m3321 48,115.9%   
Total revenues Rs m4,1461 511,790.1%   
Gross profit Rs m2673 10,503.9%  
Depreciation Rs m1221 18,707.7%   
Interest Rs m7757 134.5%   
Profit before tax Rs m400-55 -734.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1910-   
Profit after tax Rs m209-55 -383.3%  
Gross profit margin %7.01,956.2 0.4%  
Effective tax rate %47.80-   
Net profit margin %5.5-41,939.2 -0.0%  
BALANCE SHEET DATA
Current assets Rs m9,2242 485,447.4%   
Current liabilities Rs m3,573314 1,137.0%   
Net working cap to sales %148.2-240,240.8 -0.1%  
Current ratio x2.60 42,695.1%  
Inventory Days Days17618,921 0.9%  
Debtors Days Days370-  
Net fixed assets Rs m2,48036 6,950.1%   
Share capital Rs m123104 118.4%   
"Free" reserves Rs m7,018-544 -1,290.3%   
Net worth Rs m7,141-440 -1,624.2%   
Long term debt Rs m065 0.0%   
Total assets Rs m11,70338 31,150.7%  
Interest coverage x6.20 13,751.7%   
Debt to equity ratio x0-0.1 0.0%  
Sales to assets ratio x0.30 9,417.0%   
Return on assets %2.46.9 35.6%  
Return on equity %2.912.4 23.6%  
Return on capital %6.7-0.7 -971.2%  
Exports to sales %9.30-   
Imports to sales %00-   
Exports (fob) Rs m354NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3540-   
Fx outflow Rs m9740-   
Net fx Rs m-6210-   
CASH FLOW
From Operations Rs m-692-3 22,917.2%  
From Investments Rs m9521 125,210.5%  
From Financial Activity Rs m-3682 -17,440.8%  
Net Cashflow Rs m-1090 72,333.3%  

Share Holding

Indian Promoters % 0.0 52.8 -  
Foreign collaborators % 70.7 0.0 -  
Indian inst/Mut Fund % 0.9 0.0 4,450.0%  
FIIs % 0.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 29.3 47.2 62.1%  
Shareholders   44,370 5,512,029 0.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   UNIPHOS ENT    MMTC    REDINGTON    FUTURE CONSUMER    HCL INFOSYS    

Yellow Ad

Advertisement

Our FREE Guide: Small Caps That Will Race Ahead of the Sensex

Richa Agarwal, our head of smallcap research, recently released the updated version of her very popular guide:

'Small Caps That Will Race Ahead of the Sensex':

When you sign-up for Richa's One Stock Crorepati mega summit, you get this premium guide worth Rs 950 for absolutely FREE.:

Learn more



Today's Market

Why Auto Stocks are Rising, the Latest on Cryptos, and Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets rose for the third consecutive session, as prospects of a slowing economic growth fanned hopes that global central banks may go slow on interest rate hikes.

Related Views on News

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks(Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Why Tata Power Share Price is Falling(Views On News)

Jun 14, 2022

Here's why shares of Tata Power have fallen in recent days.

Is it Time to Start Buying Stocks Selectively?(Profit Hunter)

Jun 16, 2022

Some sectors have corrected by 50%. Do they merit a look?

Best Monopoly Stocks to Own in 2022(Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

When Will the Stock Market Recover?(Views On News)

Jun 15, 2022

This is how you can tell the market is going to recover.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Jun 27, 2022 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS